Reunion Neuroscience receives notice of non-compliance from Nasdaq
PremiumThe FlyReunion Neuroscience receives notice of non-compliance from Nasdaq
2y ago
Reunion Neuroscience appoints Grossman to board of directors
Premium
The Fly
Reunion Neuroscience appoints Grossman to board of directors
2y ago
Reunion Neuroscience announces abstract accepted for 2023 ASCP annual meeting
Premium
The Fly
Reunion Neuroscience announces abstract accepted for 2023 ASCP annual meeting
2y ago
Reunion Neuroscience appoints Robert Alexander, M.D as CMO
PremiumThe FlyReunion Neuroscience appoints Robert Alexander, M.D as CMO
2y ago
Reunion completes interim data analysis for Phase 1 trial with RE104
Premium
The Fly
Reunion completes interim data analysis for Phase 1 trial with RE104
2y ago
Reunion Neuroscience provides 2023 corporate update
Premium
The Fly
Reunion Neuroscience provides 2023 corporate update
2y ago
Reunion Neuroscience initiated with a Buy at EF Hutton
PremiumThe FlyReunion Neuroscience initiated with a Buy at EF Hutton
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100